Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biogaze
- Development stage
- Unknown
- Lead developer
- Novum Pharma
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Biogaze is an over-the-counter (OTC) consumer health product line developed and marketed by Novum Pharma for wound care. Available in multiple formats including hydrogels, sprays, and medicated gauzes, it is indicated for the treatment of minor skin injuries such as superficial burns, cuts, and abrasions. The product line is designed to promote healing by protecting the wound site, maintaining a moist environment, and, in specific formulations like the spray, providing antiseptic and local analgesic effects to prevent infection and alleviate pain. Biogaze is widely distributed internationally as a first-aid essential.
- Brand names
- Biogaze
Beyond the preview
Go deeper on Biogaze.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biogaze.